Skip to main content

Mayo Clinic to Use Siemens' Molecular Dx Tools

NEW YORK (GenomeWeb News) – Siemens Healthcare Diagnostics will provide the Mayo Clinic with two of its molecular testing products for use in screening for major diseases, Siemens said today.

Under the five-year agreement, the Mayo Clinic will use Siemens’ Versant and Trugene products to assess human immunodeficiency virus, hepatitis B and hepatitis C viral load, genotyping, and drug resistance.

Siemens also said it will provide planned upgrades to molecular testing systems and software over the course of the agreement as new advances in the technologies are made.

Financial terms of the agreement were not disclosed.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.